Pharmacological Profile of the “Triple” Monoamine Neurotransmitter Uptake Inhibitor, DOV 102,677

Author： Popik Piotr Krawczyk Martyna Golembiowska Krystyna Nowak Gabriel Janowsky Aaron Skolnick Phil Lippa Arnold Basile Anthony

Publisher： Springer Publishing Company

ISSN： 0272-4340

Source： Cellular and Molecular Neurobiology, Vol.26, Iss.4-6, 2006-07, pp. : 855-871

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Aspartame on Oxidative Stress and Monoamine Neurotransmitter Levels in Lipopolysaccharide-Treated Mice

By Abdel-Salam Omar

Neurotoxicity Research, Vol. 21, Iss. 3, 2012-04 ,pp. : 245-255

Springer Publishing Company

Access to resources Recommend Favorite

Striatal output markers do not alter in response to circling behaviour in 6-OHDA lesioned rats produced by acute or chronic administration of the monoamine uptake inhibitor BTS 74 398

By Lane E. L. Cheetham S. Jenner P.

Journal of Neural Transmission, Vol. 115, Iss. 3, 2008-03 ,pp. : 423-429

Springer Publishing Company

Access to resources Recommend Favorite

Antidepressants: pharmacological profile and clinical consequences

By Rahola Juan Gibert

International Journal of Psychiatry in Clinical Practice, Vol. 5, Iss. 1, 2001-06 ,pp. : 19-28

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Chronic monoamine oxidase-B inhibitor treatment blocks monoamine oxidase-A enzyme activity

By Bartl Jasmin Müller Thomas Grünblatt Edna Gerlach Manfred Riederer Peter

Journal of Neural Transmission, Vol. 121, Iss. 4, 2014-04 ,pp. : 379-383

Springer Publishing Company

Access to resources Recommend Favorite

Cholinesterase Inhibitor 6-Chlorotacrine - In Vivo Toxicological Profile and Behavioural Effects

Current Alzheimer Research, Vol. 15, Iss. 6, 2018-04 ,pp. : 552-560

Bentham Science Publishers

Access to resources Recommend Favorite